Destination market
Global Medical Tourism Statistics 2026
Global medical tourism in 2026 is sized at USD 132 billion with ~25 million patients travelling internationally for treatment, growing 11.4% CAGR. China is the #4 destination market and the fastest-growing top-10 destination for English-speaking patients.
Market size, 2021–2030
Worldwide cross-border patient flows for elective treatment.
| Year | Market size (USD) | Status |
|---|---|---|
| 2021 | USD 62.0 billion | Historical |
| 2022 | USD 78.0 billion | Historical |
| 2023 | USD 95.0 billion | Historical |
| 2024 | USD 113.0 billion | Historical |
| 2025 | USD 132.0 billion | Historical |
| 2026 | USD 147.0 billion | Latest actual |
| 2030 | USD 226.0 billion | Forecast |
Demand drivers
- Cost arbitrage: 40–80% savings vs US private rates across most major elective categories.
- Insurance coverage gaps: US underinsured population (~30 million) drives outbound dental, bariatric, cardiac.
- European waitlists (UK, Canada, Australia) drive elective orthopedic and bariatric outbound.
- Aging demographics in source markets compound elective demand.
- Telehealth-enabled pre-op consultation lowers booking friction.
Supply-side landscape
- Top-5 destinations by patient volume: Thailand (~3.5M), India (~2M), Turkey (~1.8M), China (~1.3M), Mexico (~1.2M).
- Top-5 destinations by revenue: USA (medical-tourism inbound for niche oncology and rare disease), Thailand, Singapore, India, Germany.
- Fastest-growing destination 2024–2026: China (driven by Class A international departments and proton therapy capacity).
Risks & headwinds
- Geopolitical fragmentation slows some source-destination corridors (notably US-Russia, UK-Russia, US-Iran).
- Post-pandemic flight capacity normalisation still incomplete on some long-haul routes.
- Insurer-led direct-billing networks remain fragmented outside JCI-accredited centres.
Notable providers
Bumrungrad International (Thailand)
Largest single-site medical tourism hospital globally — ~1.1M international visits/year.
Apollo Hospitals (India)
Largest Indian listed hospital group with extensive medical-tourism volume.
Class A Chinese international departments
Fastest-growing destination tier 2024–2026; concentrated in Beijing, Shanghai, Guangzhou, Shenzhen, Chengdu.
Anadolu Medical Center (Turkey)
JCI-accredited US-curriculum hospital serving European, GCC and African patients.
Related on this site
Specialty hubFull specialty pillar page
Frequently asked
- How big is the global medical tourism market in 2026?
- USD 132 billion in 2025 with ~25 million cross-border patients. Forecast to USD 226 billion by 2030 — 11.4% CAGR. The fastest-growing region is East Asia, with China the fastest-growing top-10 destination.
- What are the top medical tourism destinations 2026?
- By patient volume: Thailand, India, Turkey, China, Mexico. By revenue: USA, Thailand, Singapore, India, Germany. China is the fastest-growing top-10 destination 2024–2026.
- Who are the largest source markets for medical tourism?
- USA, UK, Germany, Russia (curtailed by sanctions), GCC (Saudi Arabia, UAE), and increasingly Vietnam, Indonesia and Mongolia for outbound flow into Chinese Class A hospitals.
Sources
- Medical Tourism Association Global Buyers Survey 2025
- Patients Beyond Borders Annual Report 2025
- Frost & Sullivan Global Medical Tourism Outlook 2026
- Allied Market Research Medical Tourism Market Report 2025
Last reviewed: 2026-05-12.
Going beyond the report
For a written quote from two Class A international departments — covering procedure, hospital match, recovery and visa — start the quote wizard.